Divisions of Human Biology and Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA 98109-1024.
Cancer Prev Res (Phila). 2014 Jan;7(1):114-27. doi: 10.1158/1940-6207.CAPR-13-0289. Epub 2013 Nov 19.
All cancers are believed to arise by dynamic, stochastic somatic genomic evolution with genome instability, generation of diversity, and selection of genomic alterations that underlie multistage progression to cancer. Advanced esophageal adenocarcinomas have high levels of somatic copy number alterations. Barrett's esophagus is a risk factor for developing esophageal adenocarcinoma, and somatic chromosomal alterations (SCA) are known to occur in Barrett's esophagus. The vast majority (∼95%) of individuals with Barrett's esophagus do not progress to esophageal adenocarcinoma during their lifetimes, but a small subset develop esophageal adenocarcinoma, many of which arise rapidly even in carefully monitored patients without visible endoscopic abnormalities at the index endoscopy. Using a well-designed, longitudinal case-cohort study, we characterized SCA as assessed by single-nucleotide polymorphism arrays over space and time in 79 "progressors" with Barrett's esophagus as they approach the diagnosis of cancer and 169 "nonprogressors" with Barrett's esophagus who did not progress to esophageal adenocarcinoma over more than 20,425 person-months of follow-up. The genomes of nonprogressors typically had small localized deletions involving fragile sites and 9p loss/copy neutral LOH that generate little genetic diversity and remained relatively stable over prolonged follow-up. As progressors approach the diagnosis of cancer, their genomes developed chromosome instability with initial gains and losses, genomic diversity, and selection of SCAs followed by catastrophic genome doublings. Our results support a model of differential disease dynamics in which nonprogressor genomes largely remain stable over prolonged periods, whereas progressor genomes evolve significantly increased SCA and diversity within four years of esophageal adenocarcinoma diagnosis, suggesting a window of opportunity for early detection.
人们普遍认为,所有癌症都是由动态的、随机的体细胞基因组进化引起的,其特征是基因组不稳定、多样性产生和基因组改变的选择,这些改变是多阶段进展为癌症的基础。晚期食管腺癌存在高水平的体细胞拷贝数改变。巴雷特食管是发展为食管腺癌的一个危险因素,已知体细胞染色体改变(SCA)发生在巴雷特食管中。绝大多数(约 95%)患有巴雷特食管的人在其一生中不会进展为食管腺癌,但一小部分人会发展为食管腺癌,其中许多人甚至在没有可见内镜异常的情况下迅速发展,而在指数内镜检查时没有明显的内镜异常。通过一项精心设计的、纵向病例队列研究,我们对 79 名接近癌症诊断的巴雷特食管进展者(进展者)和 169 名在超过 20425 人年的随访中未进展为食管腺癌的巴雷特食管非进展者(非进展者)进行了时空单核苷酸多态性阵列评估的 SCA 特征。非进展者的基因组通常具有涉及脆性位点的小局部缺失和 9p 缺失/拷贝中性 LOH,这会产生很少的遗传多样性,并在长时间的随访中保持相对稳定。随着进展者接近癌症的诊断,他们的基因组开始出现染色体不稳定性,最初出现增益和丢失、基因组多样性和 SCA 的选择,随后是灾难性的基因组倍增。我们的研究结果支持了一种不同的疾病动力学模型,其中非进展者的基因组在很长一段时间内基本保持稳定,而进展者的基因组在食管腺癌诊断后的四年内会显著增加 SCA 和多样性,这表明早期检测存在机会窗口。